Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0.14) Estimate, Sales $3.245M Beat $1.250M Estimate
Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0.14) Estimate, Sales $3.245M Beat $1.250M Estimate
Vaxart2023年第四季度GAAP每股收益（0.12）超过预期（0.14）美元，销售额324.5万美元超过12.5亿美元的预期
Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $3.245 million which beat the analyst consensus estimate of $1.250 million by 159.60 percent. This is a 14.65K percent increase over sales of $22.000 thousand the same period last year.
Vaxart（纳斯达克股票代码：VXRT）公布的季度亏损为每股0.12美元，比分析师普遍预期的0.14美元（0.14美元）高出14.29％。这比去年同期每股亏损0.18美元（0.18美元）增长了33.33％。该公司公布的季度销售额为324.5万美元，比分析师普遍预期的12.5亿美元高出159.60％。这比去年同期的22,000美元的销售额增长了14.65万个百分点。